Immunome, Inc.
IMNM
$7.91
$0.7410.32%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -80.25M | -47.10M | -36.12M | -129.49M | -92.63M |
| Total Depreciation and Amortization | 595.00K | 571.00K | 673.00K | 263.00K | 257.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 32.31M | 10.13M | 9.19M | 113.58M | 82.84M |
| Change in Net Operating Assets | 5.29M | 2.24M | 2.87M | 4.48M | -7.92M |
| Cash from Operations | -42.06M | -34.17M | -23.40M | -11.17M | -17.46M |
| Capital Expenditure | -1.38M | -47.63M | -2.34M | -2.16M | -349.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | 35.07M | -35.07M | 9.28M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 11.13M | 71.72M | -114.41M | -- | -38.93M |
| Cash from Investing | 9.76M | 24.10M | -81.69M | -37.23M | -30.00M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 20.49M | 509.00K | 1.16M | 233.60M | 371.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -400.00K | -204.00K | -469.00K | -14.16M | 55.13M |
| Cash from Financing | 20.09M | 305.00K | 694.00K | 219.45M | 55.50M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -12.22M | -9.76M | -104.39M | 171.04M | 8.04M |